XJB-5-131

Term ID

CHEBI:173099

Synonyms

(4-{[(2S)-2-{[(2S)-2-({[(2S)-1-{(2S,3E,5S)-2-benzyl-5-[(tert-butoxycarbonyl)amino]-7-methyloct-3-enoyl}pyrrolidin-2-yl]carbonyl}amino)-3-methylbutanoyl]amino}-5-{[(benzyloxy)carbonyl]amino}pentanoyl]amino}-2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl
XJB-5 131
XJB-5131
{4-[(1-{(2S,3E,5S)-2-benzyl-5-[(tert-butoxycarbonyl)amino]-7-methyloct-3-enoyl}-L-prolyl-L-valyl-N(5)-[(benzyloxy)carbonyl]-L-ornithyl)amino]-2,2,6,6-tetramethylpiperidin-1-yl}oxidanyl

(all 4)

Definition

A peptidomimetic that is an inhibitor of ferroptosis and prevents the onset of motor decline in a mouse model for Huntington's disease.

References

(all 25)

Ontology

ChEBI ( EBI )

Relationships

is a type of: aminoxyls benzyl ester carbamate ester L-ornithine derivative L-proline derivative ... Show All 10 Terms

aminoxyls benzyl ester carbamate ester L-ornithine derivative L-proline derivative L-valine derivative olefinic compound piperidines secondary carboxamide tert-butyl ester Show first 5 Terms
has_role: ferroptosis inhibitor peptidomimetic radiation protective agent radical scavenger

ferroptosis inhibitor peptidomimetic radiation protective agent radical scavenger Show first 5 Terms

Phenotype

Phenotype resulting from XJB-5-131

Phenotype where environments contain XJB-5-131

Phenotype modified by environments containing XJB-5-131

Phenotype affecting XJB-5-131

Human Disease Model